Document Status

This document has been corrected

Intratumoral oncolytic herpes virus G47∆ for residual or recurrent glioblastoma: a phase 2 trial

10.1038/s41591-022-01897-x

Published Online: 2022-07-21

Journal: Nature Medicine•Publisher: Springer Science and Business Media LLC

Authors: Hiroshi Ohtsu•Hirotaka Ito•Junji Shibahara•Minoru Tanaka•Tomoki Todo•Yasunori Ota•Yasushi Ino

This document has been corrected

Intratumoral oncolytic herpes virus G47∆ for residual or recurrent glioblastoma: a phase 2 trial

10.1038/s41591-022-01897-x

Published Online: 2022-07-21

Journal: Nature Medicine

Authors: Hiroshi Ohtsu•Hirotaka Ito•Junji Shibahara•Minoru Tanaka•Tomoki Todo•Yasunori Ota•Yasushi Ino

NOW

2025-03-18•Correction

Author Correction: Intratumoral oncolytic herpes virus G47∆ for residual or recurrent glioblastoma: a phase 2 trial

10.1038/s41591-025-03619-5

* information provided by CrossRef

2025-03-18•Correction

10.1038/s41591-025-03619-5

* information provided by CrossRef

2022-07-21•Published